# Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors

> **NCT00112645** · PHASE1 · COMPLETED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Neuroblastoma
- Sarcoma
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **DRUG:** busulfan
- **DRUG:** cyclosporine
- **DRUG:** melphalan
- **DRUG:** methotrexate
- **DRUG:** methylprednisolone
- **PROCEDURE:** allogeneic bone marrow transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation
- **PROCEDURE:** umbilical cord blood transplantation

## Key facts

- **NCT ID:** NCT00112645
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2010-04
- **Final completion:** 2011-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2013-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00112645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00112645, "Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00112645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*